Donna Santillan

Donna Santillan applies creative solutions to complex challenges in the fields of microbiology and immunology, with a particular focus on women's health. As an Associate Director at the Institute for Clinical and Translational Science, she plays a pivotal role in advancing research and education. She leads the Early Scholars Certificate in Clinical and Translational Science, a program designed to nurture the next generation of researchers in this critical field. In her capacity as the director of the Women's Health Tissue Repository, Donna oversees the collection and analysis of biological samples that are essential for understanding various health conditions affecting women. Her research as a research assistant professor of Obstetrics and Gynecology is groundbreaking, particularly in the study of vaping during pregnancy. She investigates the potential risks and effects of vaping on both maternal and fetal health, providing valuable insights into this emerging public health concern. Donna's research also delves into the long-term effects of hypertension during pregnancy. She examines how high blood pressure can impact both the mother and child, aiming to develop strategies to mitigate these risks and improve health outcomes. Her work on the placenta's role in maternal and child health further underscores her commitment to understanding the intricate biological processes that influence pregnancy and postpartum health. Her dedication to advancing women's health research is evident in her multifaceted approach, which combines clinical insights with translational science. Through her leadership and research, Donna Santillan continues to make significant contributions to the field, enhancing our understanding of pregnancy-related health issues and paving the way for improved healthcare practices.